FLOURISH PEDIATRIC ESOPHAGEAL ATRESIA G47283 FLRSH-PEA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-03-19 for FLOURISH PEDIATRIC ESOPHAGEAL ATRESIA G47283 FLRSH-PEA manufactured by Cook Endoscopy.

Event Text Entries

[142673174] Information regarding suspect medical device: product code: ptk. Common device name: tube, gastrointestinal (and accessories). Investigation evaluation: our laboratory evaluation of the product said to be involved could not confirm any device defects which could cause the device to not form an anastomosis. A visual inspection showed the oral catheter had a very dark spot along the catheter. There were some white spots on the back of the oral catheter magnet. It looked like the magnet coating had been worn down. Some of the number markings on the gastric catheter were smudged. There was some yellow substance on the feed meds port, indicating that it was used. A dimensional inspection was performed on the magnets. The magnets were measured for length and outer diameter and found to be within specification. The magnet strength was evaluated and found to be acceptable. A product-specific discrepancy that could have caused or contributed to this observation was not observed during our laboratory analysis. The device history record for the lot number said to be involved was reviewed. A discrepancy or anomaly was not observed with the product that was released for distribution. Investigation conclusion: a definitive cause for this observation could not be determined because the actual use conditions could not be duplicated in the laboratory setting. Due to a variety of clinical conditions such as patient anatomy or progression of disease state, we could not reproduce the actual conditions of product usage during our laboratory analysis. This limits our ability to conclusively determine a cause. Prior to distribution, all flourish pediatric esophageal atresia devices are subjected to a visual inspection and functional testing to ensure device integrity. A review of the device history record confirmed that the lot said to be involved met all manufacturing requirements prior to shipment. Corrective action: corrective action is not warranted at this time based on the quality engineering risk assessment. Quality assurance will continue to monitor for complaint trends and reassess the risk assessment results as post market feedback continues to become available.
Patient Sequence No: 1, Text Type: N, H10


[142673175] The physician used a cook flourish pediatric esophageal atresia device on a pediatric patient with esophageal atresia. The following was reported: on (b)(6) 2019 the flourish pediatric esophageal atresia device was placed with the patient under general anesthesia. The length of the esophageal gap prior to device placement has not been provided [slightly less than 4 cm per cook product manager]. At completion of the procedure, the flourish magnets were in the distal most portion of the esophageal ends. Per operative report dated (b)(6) 2019: the magnetic ends of the flourish device were unable to detect each other [failure to achieve anastomosis]. The flourish was removed. The following was noted in the operative report per the physician:? We proceeded to the operating room today with hopes of mobilizing each end of the esophagus to bring them closer together such that the magnets would be able to detect each other and provide sequential advancement of the esophageal ends. The esophagus was found to share a common wall with the trachea. Sharp dissection of the common wall was attempted. The proximal esophageal pouch was noted to be very high in the mediastinum and full dissection from the trachea was not achieved. The distal esophageal segment was found to be short as viewed through the chest (thoracotomy), 'perhaps 1 cm. ' traction sutures were placed on the ends of both esophageal pouches. " per cook product manager after conferring with the physician, this is a much less invasive procedure than atresia repair and was done because the trachea shared a wall with the esophagus. This was done to 'mobilize the esophagus' and will aid in future motility for the patient once the atresia is fixed [not device related]. It was reported that the facility is going to wait a few weeks for the esophageal mobilization to heal, then will consider placing a second flourish device in the patient. A section of the device did not remain inside the patient? S body. Surgery to repair the atresia has not yet been performed. According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1037905-2019-00142
MDR Report Key8432771
Date Received2019-03-19
Date of Report2019-02-22
Date of Event2019-02-21
Date Mfgr Received2019-02-22
Device Manufacturer Date2018-07-12
Date Added to Maude2019-03-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. SCOTTIE FARIOLE
Manufacturer Street4900 BETHANIA STATION RD
Manufacturer CityWINSTON-SALEM NC 27105
Manufacturer CountryUS
Manufacturer Postal27105
Manufacturer Phone3367440157
Manufacturer G1COOK ENDOSCOPY
Manufacturer Street4900 BETHANIA STATION RD
Manufacturer CityWINSTON-SALEM NC 27105
Manufacturer CountryUS
Manufacturer Postal Code27105
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameFLOURISH PEDIATRIC ESOPHAGEAL ATRESIA
Product CodePTK
Date Received2019-03-19
Returned To Mfg2019-02-27
Model NumberG47283
Catalog NumberFLRSH-PEA
Lot NumberW4091548
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCOOK ENDOSCOPY
Manufacturer Address4900 BETHANIA STATION RD WINSTON-SALEM NC 27105 US 27105


Patients

Patient NumberTreatmentOutcomeDate
10 2019-03-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.